235 related articles for article (PubMed ID: 26637396)
1. GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?
Takaku M; Grimm SA; Wade PA
Gene Expr; 2015; 16(4):163-8. PubMed ID: 26637396
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
3. Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.
Emmanuel N; Lofgren KA; Peterson EA; Meier DR; Jung EH; Kenny PA
Anticancer Res; 2018 Aug; 38(8):4435-4441. PubMed ID: 30061207
[TBL] [Abstract][Full Text] [Related]
4. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
[TBL] [Abstract][Full Text] [Related]
5. Loss of function of GATA3 induces basal-like mammary tumors.
Bai F; Zheng C; Liu X; Chan HL; Liu S; Ma J; Ren S; Zhu WG; Pei XH
Theranostics; 2022; 12(2):720-733. PubMed ID: 34976209
[No Abstract] [Full Text] [Related]
6. The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.
Du F; Yuan P; Wang T; Zhao J; Zhao Z; Luo Y; Xu B
Med Res Rev; 2015 Nov; 35(6):1300-15. PubMed ID: 26313026
[TBL] [Abstract][Full Text] [Related]
7.
Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
[TBL] [Abstract][Full Text] [Related]
8. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
[TBL] [Abstract][Full Text] [Related]
9. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
10. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.
Ma J; Liu C; Yang D; Song J; Zhang J; Wang T; Wang M; Xu W; Li X; Ding S; Zhan J; Zhang H
Sci China Life Sci; 2019 Sep; 62(9):1229-1242. PubMed ID: 31376015
[TBL] [Abstract][Full Text] [Related]
11. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
[TBL] [Abstract][Full Text] [Related]
12. GATA3 in development and cancer differentiation: cells GATA have it!
Chou J; Provot S; Werb Z
J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
[TBL] [Abstract][Full Text] [Related]
13. Mutation of GATA3 in human breast tumors.
Usary J; Llaca V; Karaca G; Presswala S; Karaca M; He X; Langerød A; Kåresen R; Oh DS; Dressler LG; Lønning PE; Strausberg RL; Chanock S; Børresen-Dale AL; Perou CM
Oncogene; 2004 Oct; 23(46):7669-78. PubMed ID: 15361840
[TBL] [Abstract][Full Text] [Related]
14. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
[TBL] [Abstract][Full Text] [Related]
15. GATA3 Truncating Mutations Promote Cistromic Re-Programming In Vitro, but Not Mammary Tumor Formation in Mice.
Cornelissen LM; de Bruijn R; Henneman L; Kim Y; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):271-284. PubMed ID: 31218575
[TBL] [Abstract][Full Text] [Related]
16. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
[TBL] [Abstract][Full Text] [Related]
17. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
[TBL] [Abstract][Full Text] [Related]
18. Arsenic reduces the GATA3 expression associated with an increase in proliferation and migration of mammary epithelial cell line MCF-10A.
Vergara-Gerónimo CA; León-Del-Rio A; Rodríguez-Dorantes M; Camacho-Carranza R; Ostrosky-Wegman P; Salazar AM
Toxicol Appl Pharmacol; 2023 Aug; 472():116573. PubMed ID: 37269932
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.
Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M
J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603
[TBL] [Abstract][Full Text] [Related]
20.
Gustin JP; Miller J; Farag M; Rosen DM; Thomas M; Scharpf RB; Lauring J
Oncotarget; 2017 Nov; 8(61):103415-103427. PubMed ID: 29262572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]